Sugi Predict

Sugi Predict / Compounds / SCHEMBL7181591

SCHEMBL7181591

SCHEMBL7181591

Cc1cccc(C)c1C(=O)Pc1c(OCCC(C)C)cc(OCCC(C)C)cc1OCCC(C)C.[LiH]

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ EPHX2 P34913 1/20 0.39
▸ TP53 P04637 3/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ MAPT P10636 2/20 0.38
▸ NR1H4 Q96RI1 2/20 0.38
▸ GALR3 O60755 1/20 0.38
▸ HSP90AA1 P07900 1/20 0.38
▸ ESR1 P03372 1/20 0.37
▸ ALOX5 P09917 2/20 0.36
▸ S1PR1 P21453 1/20 0.36
▸ S1PR5 Q9H228 1/20 0.36
▸ PPARG P37231 2/20 0.35
▸ PPARA Q07869 2/20 0.35
▸ PTGES O14684 1/20 0.35
▸ ALOX12 P18054 1/20 0.35
▸ PPARD Q03181 1/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7187585 0.92 S1PR1 (0.37) HTTMAPK1EPHX2TP53SMN1; SMN2
SCHEMBL7190109 0.89 MAPK1 (0.38) HTTMAPK1EPHX2TP53SMN1; SMN2
SCHEMBL7177474 0.88 HTT (0.40) HTTMAPK1EPHX2TP53NR1H4
SCHEMBL7184556 0.87 HTT (0.42) HTTMAPK1EPHX2SMN1; SMN2NR1H4
SCHEMBL7185561 0.86 KMT2A (0.42) MAPK1TP53MAPTNR1H4ALOX5
SCHEMBL7184637 0.86 MAPK1 (0.41) HTTMAPK1EPHX2TP53SMN1; SMN2
SCHEMBL7189924 0.86 ESR1 (0.36) HTTMAPK1EPHX2TP53SMN1; SMN2
SCHEMBL7179778 0.85 FOS (0.40) HTTSMN1; SMN2MAPTNR1H4PPARD
SCHEMBL7181815 0.85 L3MBTL1 (0.40) PPARGPPARAPPARDTDP1L3MBTL1
SCHEMBL7174863 0.85 PPARG (0.43) MAPK1TP53MAPTALOX5PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 — — US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 — — US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 — — US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 HTT 2802/4885MAPK1 1801/4885EPHX2 2476/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 HTT 2393/4885MAPK1 2710/4885EPHX2 2048/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.